NUCRYST Pharmaceuticals appoints Thomas E. Gardner to the Board of Directors
Barry M. Heck, Chairman, announced that Thomas E. Gardner has been appointed to the NUCRYST Pharmaceuticals' Board of Directors.
Mr. Gardner brings with him more than 30 years of management experience, including senior positions with both large and small healthcare companies. He is currently an industry consultant specializing in start-up concepts, strategic turnarounds and corporate finance consulting. His healthcare management experience includes 17 years in consumer healthcare marketing for Procter & Gamble and Johnson & Johnson, as well as a range of CEO-level experience within smaller healthcare companies such as IMS Health, Access Health, Datamonitor and Songbird Hearing.
Mr. Gardner holds a number of Board seats including Chairman of IntegriChain (securing supply chains for the pharmaceutical industry), Chairman of Virium Pharmaceuticals (a biopharmaceutical company focused on cancer), Director of VisiLED (LED lighting for surgeons), Lead Director of Exclaim (an Internet media company) and a position on the Advisory Board of Accélère (patient recruitment for large-scale clinical trials).
Other news from the department people
